Obesity assessment
Diagnostic TestBody mass index (BMI (kg/m2) was calculated from measurements of weight to the nearest kg and height
NCT Number: NCT04062643
The relation between obesity and stroke recurrence is still under debate. In this study it has been sought whether baseline obesity is associated with recurrent stroke and major cardiovascular events in a long-time period.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Five-years follow-up data of Ege Stroke Registry for stroke recurrence and cardiovascular events regarding to obesity were analyzed. Data include age, gender, stroke severity, neuroimaging studies, cardiovascular risk factors. Within the inclusion period, all of the included patients were followed until censoring (10th of December 2011) or readmission because of recurrent stroke, cardiovascular event or death, whichever came first. The Kaplan-Meier method was used for survival analysis. Cox proportional hazard model was applied to identify predictors of recurrent vascular events.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Body mass index (BMI (kg/m2) was calculated from measurements of weight to the nearest kg and height
Time frame: 5 years
Ischemic or hemorrhagic stroke
Ege University
Other
OBESITY ASSOCIATION WITH RECURRENT STROKE AND CARDIOVASCULAR EVENTS
Acronym: OSR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04000971
Behavior, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03481777
Brain Diseases, Cardiovascular Diseases
Aarhus, Danmark, Denmark
View Trial DetailsNCT05945784
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Pomona, California, United States
View Trial DetailsNCT03733431
Brain Diseases, Cardiovascular Diseases
Ankara, Turkey (Türkiye)
View Trial Details